Gammacord II Calculator Interface
Miles Laboratories
FDA Clearance Information
The Gammacord II Calculator Interface was cleared through the FDA 510k pathway on December 2, 1976. It is manufactured by Miles Laboratories and classified as a Class 1 device.
What It Is
FDA-Cleared Indications
- Planning tumor ablation procedures.
Clinical Applications
- Calculating treatment parameters before a tumor ablation procedure.
- Supporting clinical planning for ablation of solid tumors when ablation therapy has been selected.
- Assisting oncology and radiology professionals with treatment-planning calculations.
Practical Considerations
- The available FDA record describes a calculator interface and does not establish compatibility with current ablation generators, probes, imaging systems, or software.
- Use should follow the original labeling, operator instructions, and institutional equipment-compatibility checks.
- The device is a planning aid and does not replace imaging review, clinical judgment, or confirmation of the treatment zone during the procedure.
- The available record does not specify MRI compatibility; do not bring the interface or associated components into an MRI environment unless the manufacturer’s labeling confirms they are safe.
- The record does not provide device dimensions, service life, calibration requirements, or current availability.
Frequently Asked Questions
What is the Gammacord II Calculator Interface used for?
It is used for planning and optimizing tumor ablation procedures by calculating necessary parameters for effective treatment.
What specialties typically use this device?
Oncologists and radiologists, particularly those specializing in interventional radiology and surgical oncology, typically use this device.
What are the FDA-cleared indications?
The device is cleared for use in planning tumor ablation procedures, assisting in the calculation of ablation parameters for solid tumors.